Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
HNGE
STRONG BUYFLAGHinge Health, Inc. · Healthcare · United States · $5.8B · Avg Vol: $157M/d
Hinge Health has the strongest momentum in this batch at M92 with a buyback retiring 4.49% of shares, but value at V30 is well below the calibrated floor. Insiders sold 6.81% of shares outstanding, the largest disposal in this batch, which is decisively adverse.
COMPANY DESCRIPTION
Hinge Health, Inc. is a leading digital healthcare company specializing in musculoskeletal (MSK) care, offering virtual physical therapy and clinical coaching. The company holds a dominant market position in the digital MSK space, serving a vast portfolio of enterprise employers and health plans to reduce medical spend. It utilizes a proprietary platform combining wearable sensors, computer vision, and dedicated clinical teams to deliver personalized, home-based care.
FINANCIAL SUMMARY (USD)
| Year | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 292.7M | 390.4M | 587.9M | 41.7% | 646.3M | 822.2M | 1.0B | 32.6% |
| EPS | -1.58 | -0.15 | -7.77 | — | -8.98 | — | — | — |
| Shares | 78.0M | 78.0M | 79.2M | +1.5% | — | — | — | — |
| Debt | 15.7M | 11.1M | 8.0M | -28.5% | 7.0M | — | — | — |
| Equity | 427.3M | 416.7M | 378.5M | -5.9% | — | — | — | — |
| Op CF | -63.9M | 49.0M | 171.4M | 249.9% | 209.6M | — | — | — |
| Inv CF | 1.5M | 18.3M | -113.8M | — | — | — | — | — |
| Fin CF | -3.0M | -2.2M | -150.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of HNGE are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| HNGE | Hinge Health, Inc.(you) | $5.8B | 81 | STRONG BUY |
| TXG | 10x Genomics, Inc. | $5.9B | 75 | BUY |
| HQY | HealthEquity, Inc. | $7.9B | 84 | STRONG BUY |
| WAY | Waystar Holding Corp. | $4.3B | 64 | HOLD |
| BTSG | BrightSpring Health Services, Inc. | $14.3B | 91 | STRONG BUY |
| DOCS | Doximity, Inc. | $3.7B | 62 | HOLD |
| TDOC | Teladoc Health, Inc. | $1.6B | 76 | BUY |
| PRVA | Privia Health Group, Inc. | $3.2B | 59 | HOLD |
| OMCL | Omnicell, Inc. | $1.9B | 65 | BUY |
| GDRX | GoodRx Holdings, Inc. | $1.0B | 76 | BUY |
Peer medians: ROE -25.5% · P/E 27.7x · Gross margin 50.5%